$AKRO

first mention in our archive Aug 6, 2025 · latest 7mo ago

Mention stats

5

Mentions (12mo)

1

Voices mentioning

5 mentions since Aug 2025

Loading price chart…

@adamfeuersteinOct 9, 2025 · 10:07 AM

$NVO is acquiring $AKRO $54 per share plus a $6 VCR

@adamfeuersteinAug 28, 2025 · 4:47 PM

FDA endorses non-invasive liver imaging over biopsies for MASH drug clinical trials $AKRO $MDGL $ENTB https://t.co/tLGFAqQb8k

@adamfeuersteinAug 6, 2025 · 11:54 AM

$NVO discontinued development of FGF21-targeted MASH drug zalfermin. $AKRO $ETNB